ENHANCIN 500 mg/125 mg Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

enhancin 500 mg/125 mg

terapia s.a. - romania - kalii + acid clavulanicum - compr. film. - 500mg/125mg - peniciline cu spectru larg peniciline in combinatii incl. inhibitori de betalactamaza

RAMIRAN 2,5 mg Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ramiran 2,5 mg

terapia sa - ramiprilum - compr. - 2,5mg - inhibitori ai enzimei de conversie a angiotensinei inhibitori ai enzimei de conversie a angiotensinei

GLICLAZIDA TERAPIA 60 mg Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

gliclazida terapia 60 mg

terapia s.a. - gliclazidum - compr. elib. mod. - 60mg - antidiabetice orale sulfonamide

Laceran 10 mg comprimate Moldova - rumāņu - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

laceran 10 mg comprimate

sun pharmaceutical industries, ltd - ramiprilum - comprimate - 10 mg

Laceran 2.5 mg comprimate Moldova - rumāņu - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

laceran 2.5 mg comprimate

sun pharmaceutical industries, ltd - ramiprilum - comprimate - 2.5 mg

Laceran 5 mg comprimate Moldova - rumāņu - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

laceran 5 mg comprimate

sun pharmaceutical industries, ltd - ramiprilum - comprimate - 5 mg

Sitagliptin SUN Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

sitagliptin sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Histac comprimate filmate 150 mg Moldova - rumāņu - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

histac comprimate filmate 150 mg

sun pharmaceutical industries ltd - ranitidinum - comprimate filmate - 150 mg

Romesec capsule 20 mg Moldova - rumāņu - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

romesec capsule 20 mg

sun pharmaceutical industries ltd - omeprazolum - capsule - 20 mg

Trexyl Neo 5 mg comprimate filmate Moldova - rumāņu - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

trexyl neo 5 mg comprimate filmate

sun pharmaceutical industries ltd. - desloratadinum - comprimate filmate - 5 mg